New stock news | Unisound updates prospectus, medical + life AI dual engine powers up, commercialization process accelerates comprehensively.

On March 30, Unisound Intelligent Technology Co., Ltd. (hereinafter referred to as Unisound) updated its Hong Kong IPO prospectus, further advancing its listing process. As a pioneer in China's AGI technology, Unisound has made significant breakthroughs in the commercial application of artificial intelligence technology in recent years. Since the breakthrough of AI technology in 2017, Unisound has continuously upgraded its core AI capabilities relying on the Atlas intelligent computing platform (184 PFLOPS computing power). From the early UniCore model to the Shanhai model with 60 billion parameters, Unisound has achieved a leap in multimodal interaction and complex reasoning. Through the "technology-scene" dual-drive, Unisound has deeply integrated large models into vertical fields such as medical and daily life. It is worth noting that Unisound has not only completed the scale landing of technological solutions but also driven a significant growth in revenue and profitability. From 2022 to 2024, the company's revenue steadily increased from 601 million yuan to 939 million yuan, with a compound annual growth rate of 25%; during the same period, gross profit increased from 240 million yuan to 364 million yuan, with an average annual growth rate of 23.3%, demonstrating the company's solid commercial landing capabilities and healthy profitability level. According to data from Frost & Sullivan, in terms of revenue, Unisound is the fourth largest AI solutions provider in China in 2024, and the second-fastest growing among companies with annual revenue exceeding 500 million yuan. Also in the same year, based on revenue, the company ranks third in China in life AI solutions and fourth in medical AI services and solutions. In terms of medical AI, Unisound's AI medical solutions significantly improve medical efficiency and quality through medical record voice input, medical record quality control, single disease quality control, and medical insurance payment management. The company's system has increased medical record input speed by 4-6 times, reduced quality control time by 80%, and achieved close to expert-level intelligent review using natural language understanding and clinical knowledge graph. By 2024, the company has provided AI solutions to 166 medical customers, helping hospitals upgrade to intelligence and promote the process of medical reform. In terms of daily life AI, Unisound's AI living solutions cover various scenarios such as residential, commercial spaces, hotels, and transportation to help companies improve operational efficiency and service experience. A typical example is the Shenzhen Metro Line 20 voice ticketing system, which has reduced ticketing time from 15 seconds to 1.5 seconds, significantly relieving passenger flow pressure. From 2022 to 2024, the number of customers served by life solutions increased from 373 to 411, covering top insurance groups and metro systems, among other benchmark customers, continuously expanding service scope and deepening industry influence. Meanwhile, by providing AI large model capabilities through the MaaS model, Unisound's API call volume peak has exceeded 1 billion times per month, and AI chip sales volume has nearly doubled over three years. In the wave of industrialization of AI, the company, relying on a mature business model and deep scene accumulation, is rapidly growing into an industry leader. Looking ahead, Unisound will adhere to a balance of technological innovation and commercialization, continuously create value through full-chain layout, and lead the deep integration of AI technology with the real economy.